4Gupta AK,Ryder JE,Summerbell RC.Onychomycosis:classification and diagnosis[J].J Drugs Dermatol,2004,3 (1):51-56.
5Mishra M,Panda P,Tripathy S,et al.An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis[J].Indian J Dermatol Venereol Leprol,2005,71 (4):262-266
6Warshaw EM,Fett DD,Bloomfield HE,et al.Pulse versus continuous terbinafine for onychomycosis:a randomized,double-blind,controlled trial[J].J Am Acad Dermatol,2005,53(4):578 -584.
7Darkes MJ,Scott LJ,Goa KL.Terbinafine:a review of its use in onychomycosis in adults[J].Am J Clin Dermatol,2003,4(1):39 -65.
8Arca E,Tastan HB,Akar A,et al.An open,randomized,comparative study of oral fluconazole,itraconazole and terbinafine therapy in onychomycosis[J].J Dermatolog Treat,2002,13(1):3-9.
9Gupta AK.Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States[J].J Am Acad Dermatol,2000,43 (4Suppl):S81 -95
10De Doncker PD,Gupta AK,Marynissen G,Stoffels P,Heremans A.Itraconazole pulse therapy for ony-chomycosis and dermatomycosis:an overview[J].J Am Acad Dermatol,1997,37 (1):969-974.
2[1]Daniel CR 3rd. Traditional management of onychomycosis[J]. J Am Acad Dermatol,1996,35(3Pt 2):s21- s25.
3[2]Elewski BE. Onychomycosis: pathogenesis,diagnosis,and management[J]. Clin Microbiol Rev,1998,11(3):415- 429.
4[3]Tanuma H. Current topics in diagnosis and treatment of tinea unguium in Japan[J]. J Dermatol,1999,26(2):87- 97.
5[4]Clissold SP, Heel RC. Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses[J]. Drugs,1986,31(1):29- 51.
6[5]Bohn M, Kraemer KT. Dermatopharmacology of ciclopirox nail lacquer topical solution 8％ in the treatment of onychomycosis[J]. J Am Acad Dermatol,2000,43(4suppl 1):s57- s69.
7[6]Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8％ in the treatment of toenail onychomycosis[J]. J Am Acad Dermatol,2000,43(4suppl 1):s70- s80.
8[7]Haria M, Bryson HM. Amorolfine.A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections[J]. Drugs,1995,49(1): 103- 120.
9[8]Polak A. Kinetics of amorolfine in human nails[J].Mycoses,1993,36(3- 4):101- 103.
10[9]Reinel D. Topical treatment of onychomycosis with amorolfine 5％ nail lacquer: comparative efficacy and tolerability of once and twice weekly use[J]. Dermatology,1992,184(suppl 1):21- 24.
8Takahata Y, Hiruma M, Shiraki Y, et al. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week) [J]. Mycoses, 2009, 52(1): 72-76.
9Sikder AU, Mamun SA, Chowdhury AH, et al. Study of oral itracon- azole and terbinafine pulse therapy in onychomycosis [ J ]. My- mensingh Med J, 2006, 15 (1) :71-80.
10J. Singh,M. Zaman,A.K. Gupta.Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes. Medical Mycology . 2007
